Stuart Hinchen
Amministratore Delegato presso QuVa Pharma, Inc.
Profilo
The founder of Par Sterile Products LLC in 2007, Stuart Hinchen served as its President from 2009 to 2011.
He is also the founder of QuVa Pharma, Inc. in 2015 and currently holds the position of Chief Executive Officer.
Mr. Hinchen is also the founder of QuVa Pharma Holdings, Inc.
Posizioni attive di Stuart Hinchen
| Società | Posizione | Inizio |
|---|---|---|
QuVa Pharma, Inc.
 QuVa Pharma, Inc. Pharmaceuticals: MajorHealth Technology QuVa Pharma, Inc. provides sterile compounding pharmacy services. It develops, manufactures and distributes compounded sterile preparations. The firm provides vital compounded medications for obstetrics, OR, anesthesia, general medicine, cardiovascular, ER, and pain management. The company was founded by Stuart Hinchen and Peter Linsay Jenkins in 2015 and is headquartered in Austin, TX. | Amministratore Delegato | 01/01/2015 |
QuVa Pharma Holdings, Inc.
 QuVa Pharma Holdings, Inc. Financial ConglomeratesFinance QuVa Pharma Holdings, Inc. functions as an investment holding private company. The company is based in Sugar Land, TX. The company was founded by Stuart Hinchen. Stuart Hinchen has been the CEO since incorporation. | Amministratore Delegato | - |
Precedenti posizioni note di Stuart Hinchen
| Società | Posizione | Fine |
|---|---|---|
Par Sterile Products LLC
 Par Sterile Products LLC Pharmaceuticals: GenericHealth Technology Par Sterile Products LLC engages in the development, manufacturing, and distribution of generic pharmaceuticals. Its products include adrenalin injection, adrenalin chloride solution, aplisol, argatroban injection, brevital sodium, buprenorphine HCL injection, CIII, colistimethate for injection, USP, coly-mycin m, dantrium IV, dantrium capsules, delestrogen, dexmedetomidine HCI, injection, ethacrynate sodium for injection, USP, fluphenazine decanoate injection, USP, ketalar, pitocin, tigan, triostat, vasostrict, and zoledronic acid injection. The company was founded in 2007 and is headquartered in Chestnut Ridge, NY. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Par Sterile Products LLC
Par Sterile Products LLC Pharmaceuticals: GenericHealth Technology Par Sterile Products LLC engages in the development, manufacturing, and distribution of generic pharmaceuticals. Its products include adrenalin injection, adrenalin chloride solution, aplisol, argatroban injection, brevital sodium, buprenorphine HCL injection, CIII, colistimethate for injection, USP, coly-mycin m, dantrium IV, dantrium capsules, delestrogen, dexmedetomidine HCI, injection, ethacrynate sodium for injection, USP, fluphenazine decanoate injection, USP, ketalar, pitocin, tigan, triostat, vasostrict, and zoledronic acid injection. The company was founded in 2007 and is headquartered in Chestnut Ridge, NY. | Health Technology |
QuVa Pharma, Inc.
QuVa Pharma, Inc. Pharmaceuticals: MajorHealth Technology QuVa Pharma, Inc. provides sterile compounding pharmacy services. It develops, manufactures and distributes compounded sterile preparations. The firm provides vital compounded medications for obstetrics, OR, anesthesia, general medicine, cardiovascular, ER, and pain management. The company was founded by Stuart Hinchen and Peter Linsay Jenkins in 2015 and is headquartered in Austin, TX. | Health Technology |
QuVa Pharma Holdings, Inc.
QuVa Pharma Holdings, Inc. Financial ConglomeratesFinance QuVa Pharma Holdings, Inc. functions as an investment holding private company. The company is based in Sugar Land, TX. The company was founded by Stuart Hinchen. Stuart Hinchen has been the CEO since incorporation. | Finance |
- Borsa valori
- Insiders
- Stuart Hinchen
